Document:

Exhibit

Exhibit 10.5

CONFIDENTIAL RELEASE AND SEPARATION AGREEMENT
This Confidential Release and Separation Agreement (“Agreement”), is made effective as of December 11, 2016, by and between DAVID HALLAL, his agents, assignees, heirs, executors, administrators, beneficiaries, trustees, legal representatives and assigns (“HALLAL”), and Alexion Pharmaceuticals, Inc., its subsidiaries, parents, affiliates, divisions and related entities, and its and their successors, predecessors, assigns, present or former directors, officers, executives, agents, attorneys, shareholders, fiduciaries or employees or any person acting on behalf of any of them (“ALEXION”). 
WHEREAS, HALLAL and ALEXION are parties to an agreement of employment dated February 26, 2016 (the “Employment Agreement”); 
WHEREAS, the Employment Agreement has been terminated; 
WHEREAS, HALLAL and ALEXION wish to enter into this Agreement to fully resolve any actual or potential claims arising out of HALLAL’s employment with and/or separation from ALEXION; and
WHEREAS, ALEXION offers this Agreement without prejudice to any position ALEXION might take in any future proceeding regarding the reason for the termination of the Employment Agreement; 
NOW, THEREFORE, in consideration of the promises and mutual covenants set forth herein, HALLAL and ALEXION agree as follows:
1.    End of Employment.  HALLAL’s employment with ALEXION will end effective December 11, 2016 (the “Separation Date”).  HALLAL will be paid pursuant to section 9(a) of the Employment Agreement for all work that he performs through the Separation Date and for all accrued, unused vacation. HALLAL acknowledges that (i) with the receipt of his final paycheck, he will have received all compensation and benefits that were due to him through the Separation Date as a result of services performed for ALEXION except as provided in this Agreement; (ii) HALLAL has reported to ALEXION any and all work-related injuries incurred during employment; and (iii) that ALEXION properly provided any leave of absence because of HALLAL’s or a family member’s health condition and HALLAL has not been subjected to any improper treatment, conduct or actions due to a request for or taking such leave.
2.    Benefits Continuation.  Regardless of whether HALLAL executes this Agreement, and assuming that HALLAL was enrolled in ALEXION’s group health insurance plans prior to the Separation Date, HALLAL and his eligible dependents (if any) may continue to participate in ALEXION’s group medical, dental, vision and/or employee assistance (EAP) plans for up to eighteen (18) months following the Separation Date, subject to the terms of the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) and provided that HALLAL timely and properly elects COBRA continuation coverage and pays the premiums associated with such coverage.  HALLAL may also continue to participate in ALEXION’s Health Care Flexible Spending Account plan through the end of the calendar year if HALLAL has a balance in the plan as of the Separation Date.  HALLAL will receive information regarding COBRA in a separate mailed communication.

3.    Consideration.  Provided that HALLAL timely executes this Agreement, as consideration for this Agreement, ALEXION shall provide HALLAL with a total payment equal to $3,652,616 less applicable deductions and withholdings, payable in eight (8) equal quarterly installments commencing January 1, 2017, with each subsequent payment paid on the first business day of each quarter; provided that such payments shall cease should HALLAL fail to fully abide by the provisions of this Agreement.
4.    Non-Admission.  ALEXION’s offer of this Agreement to HALLAL and any payments made under this Agreement do not constitute an admission by ALEXION that HALLAL has any claim of any kind against ALEXION or that ALEXION admits to any liability.
5.    Release.  In exchange for the consideration described in Section 3 of this Agreement, HALLAL agrees to release ALEXION with respect to and from any and all claims, wages, agreements, contracts, covenants, actions, suits, causes of action, expenses, attorneys’ fees, damages, and liabilities of whatever kind or nature in law, equity, or otherwise, whether known or unknown, suspected or unsuspected, and whether or not concealed or hidden, which HALLAL has at any time heretofore owned or held against ALEXION, including, without limitation, those arising out of or in any way connected with HALLAL’s employment relationship with ALEXION or separation from employment with ALEXION.  This means that HALLAL gives up these claims to the fullest extent permitted by law, including:
		
	(a)
	claims for any pay, compensation or benefits, including bonuses, commissions, costs, damages, expenses, incentive pay, insurance, interest, paid or unpaid leave or time off, salary, separation or severance pay or benefits, or wages;

		
	(b)
	claims concerning any express or implied employment contracts, covenants or duties;

		
	(c)
	claims for defamation; detrimental reliance; impairment/loss of business/economic opportunity; intentional/negligent infliction of emotional distress; interference with contractual or legal rights; invasion of privacy; loss of consortium; misrepresentation; negligence including negligent hiring/retention/ supervision; personal injury; promissory estoppel; retaliatory discharge; termination notice insufficiency; tortious interference; posting requirement violations; records access violations; wrongful termination; or any other federal, state, local or common law claims;

		
	(d)
	claims of discrimination based on age, ancestry, benefit entitlement, color, concerted activity, disability, failure to accommodate, gender, gender identity or expression, genetics, harassment, income source, leave rights, marital status, military status, national origin, parental status, perception of a protected characteristic, political affiliation, race, religion, retaliation, sex, sexual orientation, union activity, veteran status or other legally protected status; claims that any payment under this Agreement was affected by any such discrimination; or any other claims under Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1866; the Civil Rights Act of 1991; the Equal Pay Act of 1963; the Age Discrimination in Employment Act (“ADEA”) and the Older Workers Benefit Protection Act; the Americans with Disabilities Act; the Family and Medical Leave Act; the Employee Retirement Income Security Act; the Sarbanes-

2

Oxley Act of 2002; the False Claims Act; the Connecticut Fair Employment Practices Act, Conn. Gen. Stat. §§ 46a-51 et seq.; the Connecticut Human Rights and Opportunities Act, Conn. Gen. Stat. § 46a-60; the Connecticut Equal Pay Law, Conn. Gen. Stat. § 31-75; or the Connecticut Family and Medical Leave Law, Conn. Gen. Stat. §§ 31-51kk et seq.; each as amended; or 
		
	(e)
	any right to be or remain a member of any class or collective action against ALEXION.

Notwithstanding anything herein to the contrary, HALLAL does not release (i) any claim or right to receive the consideration provided under this Agreement; (ii) any claim or right to indemnification by the Company under the Employment Agreement or the Indemnification Agreement between ALEXION and HALLAL entered into as of September 27, 2010; or (iii) any claim or right to continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act.
6.    Disclosure.  In addition to the foregoing, and in further exchange for the consideration described in Section 3 of this Agreement, HALLAL specifically represents and warrants that as of the date that he executes this Agreement, either (i) he has disclosed to ALEXION’s General Counsel or to another member of ALEXION’s internal Legal Department in writing any matter that he knows or suspects could constitute an actual or potential violation of the ALEXION Code of Ethics and Business Conduct or of any internal or external legal, regulatory or compliance requirement applicable to ALEXION in any jurisdiction in which it does business, or (ii) he has no information concerning any such matter.
7.    Promise Not to Sue.  HALLAL promises not to sue ALEXION for any claims covered by Section 5 of this Agreement and not excluded by any other section of this Agreement.  This promise not to sue is separate from and in addition to HALLAL’s promises in Section 5 of this Agreement, and does not apply to a claim under the ADEA.
8.    Confidentiality and Non-Disclosure.  HALLAL agrees that, except as required by applicable federal, state, or local law, HALLAL will keep all the terms of this Agreement strictly confidential, including the amount of the payment provided to HALLAL under this Agreement.  Except as required by law, HALLAL will not disclose any of the terms of this Agreement to anyone except his immediate family members and his legal/financial advisors.  Each of them is bound by this non-disclosure provision, and a disclosure by any of them will be considered a disclosure by HALLAL.  HALLAL further represents that prior to executing this Agreement, he has not disclosed its terms in a manner inconsistent with this confidentiality provision.  
9.    Continuing Obligations, Condition.  HALLAL acknowledges and agrees that all confidentiality and non-disclosure obligations survive HALLAL’s separation from ALEXION and remain in full force and effect. HALLAL further agrees, as a condition of this Agreement, to execute the Proprietary Information and Inventions Agreement attached as Addenda hereto. HALLAL further acknowledges and agrees that he continues to be bound by the Non-Competition, Non-Solicitation, and Non-Disparagement provisions in section 5 of the Employment Agreement, which survive HALLAL’s separation from ALEXION and remain in full force and effect.

3

10.    Return of ALEXION Assets.  HALLAL agrees that he has returned or will return immediately, and no later than the Separation Date, all ALEXION property or assets that he had or controlled during his employment, including: his identification badge; key fob; lab notebooks; laptop, desktop and handheld computers; smartphones; personal digital assistants (PDAs); secure ID cards; keys; tools and tool boxes; personal protective equipment; external hard drives; flash drives; power and sync cables; all originals and soft or hard copies of documents such as e-mails, facsimiles, handbooks, letters, manuals, or memoranda; any personal documents or materials containing confidential ALEXION information, including personal notebooks or planners; and any other ALEXION related communications,  material, hardware, equipment or property.  The requirements of this Section apply regardless whether such property, assets, documents or other materials are located or stored (a) at ALEXION’s offices or other location (including but not limited to HALLAL’s personal residence) or (b) on ALEXION’s systems or equipment or any other system or equipment (including but not limited to HALLAL’s personal system or equipment). 
11.    Resignation. By signing this Agreement, HALLAL hereby resigns from any and all positions that he holds as a director or officer of ALEXION or its affiliates, including his positions as Chief Executive Officer, member of the Board of Directors, and member of the Board of Directors for the Pharmaceutical Research and Manufacturers of America.  HALLAL agrees to execute the letter of resignation attached hereto as Exhibit A.  
12.    Agreed Statements.  The parties agree that ALEXION and HALLAL will issue public statements regarding HALLAL’s resignation substantially in the forms attached hereto as Exhibit B and will limit any public statements regarding HALLAL’s termination of employment with ALEXION to such agreed statements. The parties agree that the release of said public statements will not violate the terms of any confidentiality provision, or any other provision, contained in this Agreement or any other agreement between the parties.  The public statements attached hereto are incorporated herein by reference.  If ALEXION is contacted for a reference, ALEXION will confirm dates of employment and job title in accordance with ALEXION policy and will not make any other statements to the party requesting a reference. 
13.    Cooperation.  HALLAL agrees to cooperate with, and assist, ALEXION to ensure a smooth transition of his work responsibilities.  At any time following the Separation Date, HALLAL will provide such information as ALEXION may reasonably request with respect to any ALEXION-related transaction or other matter in which HALLAL was involved in any way while employed by ALEXION.  HALLAL further agrees to assist and cooperate with ALEXION in connection with the defense, prosecution, government investigation, or internal investigation of any claim or matter that may be made against, concerning, or by ALEXION. Such assistance and cooperation shall include timely, comprehensive, and truthful disclosure of all relevant facts known to HALLAL, including through in-person interview(s) with ALEXION’s internal Legal Department or outside counsel for ALEXION.  HALLAL shall be entitled to reimbursement for all properly documented expenses incurred in connection with rendering services under this Section, including, but not limited to, reimbursement for all reasonable travel, lodging, and meal expenses.
14.    Non-Interference with Rights.  The Release set forth in Section 5 of this Agreement excludes any claims which cannot be waived by law, such as claims for unemployment/worker 

4

compensation, or claims for vested/earned benefits under ERISA-covered employee benefit plans as applicable on the date that HALLAL signs this Agreement.  Further, HALLAL understands, agrees and acknowledges that nothing contained in this Agreement, including but not limited to Sections 5 (Release), 6 (Disclosure), 7 (Promise Not to Sue), 8 (Confidentiality and Non-Disclosure), 9 (Continuing Obligations), 10 (Return of ALEXION Assets), 12 (Agreed Statement), 13 (Cooperation), or 15 (Remedies), shall prohibit or restrict HALLAL from filing a charge or complaint with, reporting possible violations of any law or regulation, making disclosures to, and/or participating in any investigation or proceeding conducted by the National Labor Relations Board, the Equal Employment Opportunity Commission, the U.S. Department of Labor, the Securities and Exchange Commission, and/or any other governmental agency or entity, or from exercising rights under Section 7 of the National Labor Relations Act to engage in joint activity with other employees, and that notwithstanding any other provision in this Agreement, HALLAL is not required to seek authorization from ALEXION or to notify ALEXION before doing so.
15.    Remedies.  HALLAL agrees that if he is found by ALEXION to have violated this Agreement, ALEXION will cease any remaining payments under Section 3 and HALLAL will pay ALEXION’s reasonable attorneys’ fees, court costs and other expenses to enforce this Agreement, in addition to any other available relief.
16.    Choice of Law and Forum.  This Agreement shall be governed by and construed under the laws of the State of Connecticut, without regard to its conflicts of law rules.  The parties hereby consent to the jurisdiction of the federal and state courts located in the State of Connecticut to resolve any disputes arising out of the interpretation or administration of this Agreement.  
17.    Successors.  This Release shall be binding upon and inure to the benefit of HALLAL, ALEXION, and their respective heirs, representatives, executors, administrators, successors, insurers, and assigns, and shall inure to the benefit of each and all of the Released Parties.
18.    Severability.  The provisions of this Agreement are severable, and if any part of it is found to be unenforceable or invalid, the other Sections shall remain fully valid and enforceable.  
19.    Representations.  HALLAL acknowledges and agrees that:
		
	(a)
	he has, by being given a copy of this Agreement, been advised to consult with an attorney of his own choice, and he has been given the opportunity to do so prior to signing this Agreement; 

		
	(b)
	he has not been promised anything besides what is in this Agreement; 

		
	(c)
	the payment described in this Agreement exceeds the amount that he otherwise would receive at the end of his employment with ALEXION, and provides adequate and sufficient consideration to support this Agreement; 

		
	(d)
	he has reviewed this Agreement and is signing this Agreement knowingly and voluntarily;

5

		
	(e)
	he has not been coerced or threatened into signing this Agreement;

		
	(f)
	he was not required to waive any attorneys’ fees as a condition of this Agreement; and

		
	(g)
	this Agreement can only be modified in a written document signed by both HALLAL and ALEXION.

20.    Entire Agreement, Acknowledgement.  This Agreement sets forth the entire agreement between the parties on the subject matter herein.  HALLAL is not relying on any other agreements or oral representations not fully addressed in this Agreement.  Any prior agreements between or directly involving HALLAL and ALEXION, including the Employment Agreement, are superseded by this Agreement, except that HALLAL acknowledges that (i) this Agreement shall not in any way affect, modify, or nullify any prior agreement that HALLAL entered into with ALEXION regarding confidentiality, trade secrets, inventions, or unfair competition, and (ii) section 5 (Non-Competition, Non-Solicitation and Non-Disparagement) of the Employment Agreement shall survive and remain in full force and effect. HALLAL further acknowledges that the restraints set forth in section 5 of the Employment Agreement are necessary for the reasonable and proper protection of ALEXION and are reasonable in respect to subject matter, length of time, and geographic area.  To the extent of any conflict between the terms of this Agreement and any other document concerning severance benefits, the provisions of this Agreement shall prevail. The headings in this Agreement are provided for reference only and shall not affect the substance of this Agreement.
21.    Execution.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, and together, all of which shall constitute one original document.  Original signatures that are transmitted by fax or electronic mail shall be considered original signatures under this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement.
    
    
__/s/ David Hallal______     Date: __12/11/16____
DAVID HALLAL

    
ALEXION PHARMACEUTICALS, INC.

By: /s/ Clare Carmichael_____Date: 12/11/16
Name: Clare Carmichael
Title:      Executive Vice President and 
Chief Human Resources Officer

6Exhibit

Exhibit 10.6

EMPLOYMENT AGREEMENT
This EMPLOYMENT AGREEMENT (the “Agreement”) dated as of December 12, 2016 by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and David Brennan (the “Employee”).
WITNESSETH
WHEREAS, the Company agrees to employ the Employee on an interim basis during the Company’s search for a permanent Chief Executive Officer, subject to the terms and conditions contained in this Agreement; and
WHEREAS, the Employee agrees to accept employment with the Company, subject to the terms and conditions contained in this Agreement.
NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements herein contained, the parties hereto agree as follows:
		
	1.
	Employment Duties and Acceptance.

(a)    The Company hereby employs the Employee, for the Interim Term (as hereinafter defined), to render full-time services to the Company as Interim Chief Executive Officer (“Interim CEO”) and to perform such duties commensurate with such office or other office as the Employee shall reasonably be directed by the Company to perform. The Employee hereby accepts such employment and agrees to render the services described above. In his capacity as Interim CEO the Employee shall report to the Board of Directors of the Company (the “Board”). During the Interim Term, the Company expects that Employee will also continue to serve as a Director on the Board.
(b)    During the Interim Term, the Employee shall devote his full business time and his best efforts, business judgment, skill and knowledge exclusively to the advancement of the business and interests of the Company and its Affiliates and to the discharge of his duties and responsibilities hereunder. Notwithstanding anything to the contrary herein, although the Employee shall provide services as a full time employee, it is understood that the Employee, with consent of the Board, may (1) have non full-time academic appointments; (2) participate in professional activities; (3) publish academic articles; (4) participate in community and/or philanthropic activities; and (5) serve on a board of directors, governing body, or in any other capacity with a company or organization engaged in activities unrelated to the business of the Company and may receive compensation in exchange for such service (collectively, “Permitted Activities”); provided, however, that such Permitted Activities do not interfere with the Employee’s duties to the Company or create a conflict of interest for the Employee. The Employee shall perform Employee’s duties in compliance with (i) this Agreement, (ii) all applicable laws and regulations, and (iii) Company’s policies and practices, including its Employee Code of Ethics and Business Conduct, Equal Opportunity and Anti-Harassment policies, and compliance policies. 
		
	2.
	Term of Employment.

(a)    The term of the Employee’s interim employment under this Agreement shall commence as of December 12, 2016 (the “Effective Date”) and shall end the sooner of twenty-six (26) weeks after the Effective Date and the date on which a permanent successor CEO is hired and commences employment with the Company, unless sooner terminated as described in Section 2(b). Unless notice is given by the Employee or the Company at least thirty (30) days prior to the expiration of the Term of this Agreement (or at least thirty (30) days prior to the expiration of any extension hereof), the Term of the Agreement shall, if it has not previously terminated, be automatically extended by one (1) month from the date it would otherwise end (whether upon expiration of the original Term or any extension(s) thereof). The term of this Agreement as from time to time extended or renewed is hereafter referred to as the “Term of this Agreement” or the “Interim Term.”
(b)    During the Interim Term, the Employee’s employment service is “at will” and may be terminated by the Employee or the Company at any time, with or without cause, with 30 days’ advanced written notice by either party to the other. The Company expects that the Employee will remain on the Board as a non-employee director following the end of the Interim Term. 
		
	3.
	Compensation and Benefits.

(a)    As compensation for services to be rendered pursuant to this Agreement, the Company agrees to pay the Employee, during the Term, an annualized salary of $6,000,000 (the “Salary”), payable pro rata in bi-weekly installments in accordance with the Company’s regular payroll practices. 
(b)    Equity.
(i)    While the Employee serves as both Interim CEO and a director of the Board, the Employee shall not earn any non-employee director cash retainers, equity grants, or other compensation under the Company’s Director Compensation Program for his services as Director; however, the Employee will be entitled to receive the same type of annual equity award with respect to the same number of shares of the Company’s common stock as the Employee would have been entitled to receive had he continued to serve as one of the Company’s non-employee directors (the “New Equity Award”), such award for 2017 to be granted to the Employee at the same time as 2017 annual awards are made to our non-employee directors, on or about May 2017 (the “Grant Date”). 
(ii)    The Employee’s existing outstanding equity awards will continue to vest and/or become exercisable, or be settled in shares, as applicable, during and after the Interim Term in accordance with their original schedules, provided the Employee continues to provide services to the Company. 
(iii)    Unless the Compensation Committee of the Board otherwise determines in its sole discretion, and to the extent consistent with applicable law, (A) the Employee will not be eligible to participate in any Company cash-based or equity-based incentive plans or programs applicable to the Company’s Senior Officers (collectively, the “Senior Officer Plans”), including, 

2

without limitation, any severance plan, change in control plan, cash bonus plan, and (B) the Employee will not be eligible to participate in any Company compensation or employee benefit plan, program, or agreement or policy (collectively with the Senior Officer Plans, “Plans”), except as set forth in this Agreement or otherwise required by applicable regulations. 
(c)    The Company shall pay or reimburse the Employee for all reasonable, customary and necessary business expenses actually incurred or paid by the Employee during the Term in the performance of services under this Agreement, subject to travel and other policies and such reasonable substantiation and documentation as may be required by the Company from time to time, subject to Section 12(g) of this Agreement. During the Term, the Company agrees to pay the Employee a housing allowance of $5,000 per month and to reimburse the Employee for reasonable commuting expenses, including but not limited to use of a rental car and airfare or other transportation costs from the Employee’s personal residences  to New Haven, CT, consistent with the Company’s travel policies, subject to Section 12(g) of this Agreement. 
		
	4.
	Confidentiality.

As part of the consideration for the compensation and benefits to be paid to the Employee hereunder, and as additional incentive for the Company to enter into this Agreement, the Employee agrees to execute prior to the Effective Date, and to abide by, the Proprietary Information and Inventions Agreement previously entered into with the Company, the terms of which shall survive the termination of this Agreement. 
		
	5.
	Non-Competition, Non-Solicitation and Non-Disparagement.

During the Term, the Employee shall not (1) provide any services, directly or indirectly, to any other business or commercial entity without the consent of the Company, which may be withheld in the Company’s sole discretion, or (2) participate in the formation of any business or commercial entity without the consent of the Company, which may be withheld in the Company’s sole discretion; provided, however, that nothing contained in this Section 5 shall be deemed to prohibit the Employee from acquiring, solely as an investment, shares of capital stock (or other interests) of any corporation (or other entity) not exceeding 2% of such corporation’s (or other entity’s) then outstanding shares of capital stock and provided, further, that nothing contained herein shall be deemed to limit the Employee’s Permitted Activities pursuant to Section 1(b).
		
	6.
	Cooperation.

At any time following the termination of his employment for any reason, Employee will provide such information as the Company may reasonably request with respect to any Company-related transaction or other matter in which Employee was involved in any way while employed by the Company. Employee further agrees to assist and cooperate with the Company in connection with the defense, prosecution, government investigation, or internal investigation of any claim or matter that may be made against, concerning, or by the Company. Such assistance and cooperation shall include timely, comprehensive, and truthful disclosure of all relevant facts known to the Company, including through in-person interview(s) with the Company’s internal 

3

Legal Department or outside counsel for the Company. Employee shall be entitled to reimbursement for all properly documented expenses incurred in connection with rendering services under this Section, including, but not limited to, reimbursement for all reasonable travel, lodging, and meal expenses.
		
	7.
	Indemnification.

The Company shall indemnify the Employee to the fullest extent permitted by applicable law and its then-current articles of incorporation and by-laws. The Employee agrees to promptly notify the Company of any actual or threatened claim arising out of or as a result of his employment with the Company. The Company shall provide, at its expense, Directors and Officers insurance for the Employee in amounts reasonably satisfactory to the Employee, to the extent such insurance is available at reasonable rates, which determination shall be made by the Board. 
		
	8.
	Representations by Employee.

The Employee represents and warrants that he has full right, power and authority to execute the terms of this Agreement; this Agreement has been duly executed by the Employee and such execution and the performance of this Agreement by the Employee does not result in any conflict, breach or violation of or default under any other agreement or any judgment, order or decree to which the Employee is a party or by which he is bound. 
		
	9.
	Arbitration.

Any controversy or claim arising out of or relating to this Agreement or the breach thereof, or arising out of Employee’s employment and the termination of such employment, shall be settled by arbitration in Connecticut, in accordance with the employment dispute rules then existing of the American Arbitration Association, before a single arbitrator appointed in accordance with such rules. The arbitrator shall have authority to grant any form of appropriate relief, whether legal or equitable in nature. Judgment on the award may be entered in any court having jurisdiction. The parties shall be free to pursue any remedy before the arbitrator that they shall be otherwise permitted to pursue in a court of competent jurisdiction. As a material part of this agreement to arbitrate claims, the Employee and the Company expressly waive all rights to a jury trial in court on all statutory or other claims. The award of the arbitrator shall be final and binding. The costs of the American Arbitration Association and the arbitrator will be borne equally by the Company and the Employee. Nothing contained herein, however, shall limit the right of the Company or any of its Affiliates to seek equitable or other relief from any court of competent jurisdiction for violation of any provision of Sections 4 and 5 above.
		
	10.
	Recoupment.

The Employee hereby acknowledges and agrees that the equity award described in Section 3(b) and all other payments of incentive-based compensation payable to the Employee by the Company or its Affiliates (whether under this Agreement or otherwise) shall be subject to any applicable clawback or recoupment policy of the Company, as such policy may be amended 

4

and in effect from time to time, and shall be subject to recoupment as otherwise required by applicable law or applicable stock exchange listing standards, including, without limitation, Section 10D of the Securities Exchange Act of 1934, as amended.
		
	11.
	Notices.

All notices, requests, consents and other communications required or permitted to be given hereunder shall be in writing and shall be deemed to have been duly given if sent by private overnight mail service (delivery confirmed by such service), registered or certified mail (return receipt requested and received), telecopy (confirmed receipt by return fax from the receiving party) or delivered personally, as follows (or to such other address as either party shall designate by notice in writing to the other in accordance herewith):
If to the Company:
Alexion Pharmaceuticals, Inc.
100 College Street
New Haven, Connecticut 06510
Telephone: (203) 272-2596
Fax: (203) 271-8198
Attn: General Counsel

If to the Employee: to the Employee’s Address on file with the Company.
		
	12.
	General.

(a)    This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Connecticut applicable to agreements made and to be performed entirely in Connecticut by Connecticut residents.
(b)    This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter hereof, and supersedes all prior agreements, arrangements and understandings, written or oral, relating to the subject matter hereof, except for the Proprietary Information and Inventions Agreement and the Indemnification Agreement. No representation, promise or inducement has been made by either party that is not embodied in this Agreement, and neither party shall be bound by or liable for any alleged representation, promise or inducement not so set forth.
(c)    This Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms or covenants hereof may be waived, only by a written instrument executed by the parties hereto, or in the case of a waiver, by the party waiving compliance. The failure of a party at any time or times to require performance of any provision hereof shall in no manner affect the right at a later time to enforce the same. No waiver by a party of the breach of any term or covenant contained in this Agreement, whether by conduct or otherwise, or any one or more or continuing waivers of any such breach, shall constitute a waiver of the breach of any other term or covenant contained in this Agreement.

5

(d)    This Agreement shall be binding upon the legal representatives, heirs, distributees, successors and assigns of the parties hereto. The Company may not assign its rights and obligation under this Agreement without the prior written consent of the Employee, except to a successor of substantially all the Company’s business which expressly assumes the Company’s obligations hereunder in writing. In the event of a sale of all or substantially all of the assets of the Company, the Company shall use its best efforts to cause the purchaser to expressly assume this Agreement. The Employee may not assign, transfer, alienate or encumber any rights or obligations under this Agreement, except by will or operation of law, provided that the Employee may designate beneficiaries to receive any payments permitted under the terms of the Company’s benefit plans.
(e)    If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
(f)    Provisions of this Agreement shall survive any termination of employment if so provided herein or if necessary or desirable fully to accomplish the purposes of other surviving provisions, including without limitation, the obligations of the Employee under Section 5 hereof. Upon termination of the Employee’s employment hereunder by either the Employee or the Company as permitted hereby, all rights, duties and obligations of the Employee and the Company to each other pursuant to this Agreement shall cease, except for the provisions hereof that contemplate performance after termination, including without limitation the obligations of the Employee under Section 5 hereof.
(g)    This Agreement is intended to comply with the applicable requirements of Section 409A and shall be construed accordingly. Each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. In no event shall the Company have any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with, or be exempt from, the requirements of Section 409A. Any taxable reimbursement due under the terms of this Agreement shall be paid no later than December 31 of the year after the year in which the expense is incurred and shall comply with Treas. Reg. § 1.409A-3(i)(1)(iv).

6

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 
ALEXION PHARMACEUTICALS, INC.

By: ___/s/ Clare Carmichael______________
Name: Clare A. Carmichael
Title: EVP & Chief Human Resources Officer

EMPLOYEE

__/s/ David Brennan_____________________
David Brennan

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]